Takeda Pharmaceutical (TAK) EBT Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) EBT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | -26.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19% |
| Mar 31, 2026 | -4.08% |
| Dec 31, 2025 | -80.68% |
| Sep 30, 2025 | 65.59% |
| Jun 30, 2025 | -4.68% |
| Mar 31, 2025 | -19.87% |
| Dec 31, 2024 | -45.99% |
| Sep 30, 2024 | 50.25% |
| Jun 30, 2024 | -24.47% |
| Mar 31, 2024 | -9.33% |
| Dec 31, 2023 | -32.44% |
| Sep 30, 2023 | 275.30% |
| Jun 30, 2023 | -6.65% |
| Mar 31, 2023 | -20.35% |
| Sep 30, 2022 | 33.56% |
| Jun 30, 2022 | 135.55% |
| Mar 31, 2022 | 120,848.33% |
| Dec 31, 2021 | 14.60% |
| Sep 30, 2021 | 97,494.74% |
| Jun 30, 2021 | 33.25% |